New LED Microscope Completes Line of Clinical and Research Tools
|
By LabMedica International staff writers Posted on 26 Jul 2015 |
A popular microscope used for both clinical and research applications is now available with LED illumination.
The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools for demanding tasks in life science routine and research applications. With their powerful transmitted light illumination, high-quality optical performance, and state-of-the-art accessories, the Leica DM2500 and DM2500 LED are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
The difference between the two microscopes is their illumination: The Leica DM2500 LED is equipped with LED illumination for transmitted light, whereas the Leica DM2500 works with halogen. Both types of illumination render a realistic impression of the colors of the sample, so that users in clinical applications, such as the frequently used HE specimen staining, are able to assess the colors of their samples accurately. With the launch of the Leica DM2500 LED, Leica Microsystems has completed its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The microscopes are certified for in vitro diagnostics (IVD) use.
The ultra-bright LED illumination of the newly released Leica DM2500 LED offers a constant color temperature at all light intensities, enabling particularly fine differentiation of colors in stained specimens. Users benefit from the brightness and color accuracy of the LED illumination in all other transmitted light contrasting techniques, such as brightfield, polarized light, and darkfield. LEDs offer the general advantages of no sample heating, low energy consumption, and long life time.
"The specially-developed LED illumination makes the Leica DM2500 LED an ideal microscope for challenging experiments requiring different contrasting techniques and for users who prefer a manual instrument," said Dr. Jasna Gilbert, product manager at Leica Microsystems. "The Leica DM2500 LED has now completed our DM1000 to 3000 series. All the models are available with either LED or halogen illumination. Besides the new illumination, the Leica DM2500 LED offers all the other benefits of the microscope series such as the unique ergonomics design for user comfort and convenience."
Related Links:
Leica
The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools for demanding tasks in life science routine and research applications. With their powerful transmitted light illumination, high-quality optical performance, and state-of-the-art accessories, the Leica DM2500 and DM2500 LED are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
The difference between the two microscopes is their illumination: The Leica DM2500 LED is equipped with LED illumination for transmitted light, whereas the Leica DM2500 works with halogen. Both types of illumination render a realistic impression of the colors of the sample, so that users in clinical applications, such as the frequently used HE specimen staining, are able to assess the colors of their samples accurately. With the launch of the Leica DM2500 LED, Leica Microsystems has completed its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The microscopes are certified for in vitro diagnostics (IVD) use.
The ultra-bright LED illumination of the newly released Leica DM2500 LED offers a constant color temperature at all light intensities, enabling particularly fine differentiation of colors in stained specimens. Users benefit from the brightness and color accuracy of the LED illumination in all other transmitted light contrasting techniques, such as brightfield, polarized light, and darkfield. LEDs offer the general advantages of no sample heating, low energy consumption, and long life time.
"The specially-developed LED illumination makes the Leica DM2500 LED an ideal microscope for challenging experiments requiring different contrasting techniques and for users who prefer a manual instrument," said Dr. Jasna Gilbert, product manager at Leica Microsystems. "The Leica DM2500 LED has now completed our DM1000 to 3000 series. All the models are available with either LED or halogen illumination. Besides the new illumination, the Leica DM2500 LED offers all the other benefits of the microscope series such as the unique ergonomics design for user comfort and convenience."
Related Links:
Leica
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest BioResearch News
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Distinguishes Deadly Cardiac Events
Two life-threatening cardiovascular emergencies—myocardial infarction and aortic dissection—often present with the same symptom: sudden, severe chest pain. Yet the treatments for these conditions are fundamentally... Read more
Blood Test Tracks Transplant Health Using Donor DNA
Organ transplantation offers life-saving treatment for patients with end-stage disease, but complications such as rejection remain a constant risk. Monitoring transplanted organs typically relies on invasive... Read moreMolecular Diagnostics
view channel
Precision Analyzer Reveals ‘Chameleon Proteins’ Causing Intractable Diseases
Understanding how proteins behave inside the body is essential for uncovering the causes of many complex diseases. While most proteins function based on stable three-dimensional structures, a large portion... Read more
Alzheimer's Blood Marker Could Improve Detection of Heart and Kidney Diseases
A blood protein widely used as an early indicator of Alzheimer’s disease may not be as specific as once thought. Researchers have now found that phosphorylated tau (pTau), a key biomarker linked to ne... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more
Immune Signature Identified in Treatment-Resistant Myasthenia Gravis
Myasthenia gravis is a rare autoimmune disorder in which immune attack at the neuromuscular junction causes fluctuating weakness that can impair vision, movement, speech, swallowing, and breathing.... Read more
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read moreBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read moreMicrobiology
view channel
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read more
New Chromogenic Culture Media Enable Rapid Detection of Candida Infections
Invasive Candida infections are challenging for healthcare systems, with some strains spreading rapidly in hospitals and showing resistance to multiple antifungal drugs. Candida auris is associated with... Read moreTechnology
view channel
New Electronic Pipette Enhances Workflows with Touchscreen Control
Manual pipetting remains a routine yet error-prone step that can affect reproducibility and throughput in clinical and research laboratories. Training demands and ergonomic strain also add variability... Read more
AI Model Outperforms Clinicians in Rare Disease Detection
Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read moreIndustry
view channel
New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network
Lucent Diagnostics, a brand of Quanterix Corporation, has partnered with Life Line Screening (LLS) to offer Lucent’s non‑invasive, blood‑based biomarker test across the United States. Programs are... Read more
MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition
MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical
Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more







 Analyzer.jpg)

